The clinical utility of neostigmine administration in the diagnosis of acquired myasthenia gravis.
Harry CridgeAlison LittleRoberto José-LópezTheresa PancottoJennifer R MichaelsMarika MenchettiAnna SuñolDavid LipsitzMichaela J BeasleyPublished in: Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001) (2021)
The neostigmine challenge appears to be safe and viable alternative to the previously utilized edrophonium challenge, particularly when weak positive responses are considered negative for acquired MG. Polymyositis cases may have a false positive response to neostigmine challenge.